|
The Cytotherapy Best Paper Award
The Cytotherapy Best Paper Award is for the best overall original paper published in a given volume of Cytotherapy, the official journal of the International Society for Cellular Therapy.
The Award consists of a check for $2500 and a plaque. The award is presented at the gala dinner of each Annual ISCT Meeting. The judging committee is the ISCT Education and Publications Committee.
Judging criterion will include consideration of the paper's quality, the significance of the contribution to the field, the degree to which the science presented is novel, and the applicability of the science presented to improvements in processing or engineering cells for potential therapeutic purposes.
Award Winners
Volume 7 (2005)
Potent in vivo anti-tumor activity of isolated CD62Llow lymph node cells sensitized in vivo with tumor lysate-pulsed DC-based vaccines
Z. Liu, H Fan, Y Wu and B Chen
Department of Thoracic Surgery, Tongji University Affiliated East Hospital, China, Division of Hematology/Oncology, Department of Pediatrics, Yale University School of Medicine, New Haven, CT, USA
Cytotherapy (2005) Vol. 7, No. 4, 353-362
Volume 6 (2004)
Isolation and characterization of mesenchymal progenitor cells from chorionic villi of human placenta
K Igura, X Zhang, K Takahashi, A Mitsuru, S Yamaguchi and TA Takahashi
Division of Cell Processing, Institute of Medical Science, The University of Tokyo and Yamaguchi Hospital
Cytotherapy (2004) Vol. 6, No. 6, 543-553
Volume 5 (2003)
Delivery of Herpes Simplex Thymidine Kinase Bystander Effect by Engineered Human Mesothelial Cells for the Treatment of Ovarian Cancer
C Rancourt, C Bergeron, D Lane, G Garon and A Piché
Départment de Microbiologie et Infectiologie, Faculté de Médecine, Université de Sherbrooke, Canada
Cytotherapy (2003) Vol. 5, No. 6, 509-522
Volume 4 (2002)
Optimized clinical-scale culture conditions for ex vivo selective depletion of host-reactive donor lymphocytes: a strategy for GvHD prophylaxis in allogeneic PBSC transplantation
SR Solomon, T Tran, CS Carter, S Donnelly, N Hensel, J Schindler, E Bahceci, V Ghetie, J Michálek, D Mavroudis, EJ Read, ES Vitetta, AJ Barrett
Stem Cell Allotransplantation Section, Hematology Branch, NHLBI, National Institutes of Health, Bethesda, MD, USA
Cytotherapy (2002) Vol. 4, No. 5, 395-406
Volume 3 (2001)
Allogeneic hematopoietic cell transplantation without myeloablative conditioning for patients with advanced hematologic malignancies
G Gürman, M Arat, O Ilhan, N Konuk, M Beksac, H Celebi, M Özcan, Ö Arslan, C Üstün, H Akan, A Uysal and H Koc
Ankara University Medical School, Department of Hematology and Transplantation Unit, Ankara, Turkey
Cytotherapy (2001) Vol. 3, No. 4, 253-260
Volume 2 (2000)
Minimal tumor contamination of hematopoietic harvests from breast cancer patients can be easily detected by liquid culture assay
N Gibelli, A Lanza, P Pedrazzoli, L Ponchio, B Oliviero, L Duma, GA DA Prada, C Zibera and G Robustelli Della Cuna
Divisione di Oncologia Medica, IRCCS Fondazione ‘S. Maugeri’ – 27100 Pavia, Italy
Cytotherapy (2000) Vol. 2, No. 1, 39-44
Volume 2 (2000)
Transplantation with Low Density Autologous Peripheral Blood Stem Cells Prepared with BDS60 for Women with Stage II, III and IV Breast Cancer
GG Laport, FH Valone, TM Zimmerman, DL Grinblatt, P Van Vlasselaer, BJ Still and SF Williams
University of Chicago, Chicago, IL, USA, Dendreon Corporation, Seattle, WA, USA
Cytotherapy (2000) Vol. 2, No. 3, 179-186
Volume 1 (1999)
The CD34+Cell Concentration in Peripheral Blood Predicts CD34+ Cell Yield in the Leukapheresis Product
KL Hollingsworth, TM Zimmerman, T Karrison, A Oliver, and SF Williams
Department of Medicine, Hematology/Oncology Section, Department of Health Studies, Department of Pathology, University of Chicago Medical Center, Chicago USA
Cytotherapy (1999) Vol. 1, No. 2, 141-146
| 
